Johnson & Johnson alleges that a Pfizer ad for children's Advil that ran in medical journals violated a 1989 court order barring claims that products are like or comparable to children's Tylenol. J&J filed a cease-and-desist letter, and Pfizer responded with a lawsuit contending that J&J is improperly attempting to expand the scope of the court order and is depriving doctors and consumers of useful, truthful information.
Johnson & Johnson and its McNeil PPC unit are facing a lawsuit filed by parents of Markus Cherry, a 3-month-old baby who died three days after taking Tylenol Infants' Drops in 2010. According to the FDA, bacterial contamination prompted McNeil to withdraw the product from the market two weeks after the infant's death.
McNeil Consumer Healthcare withdrew one lot, or about 34,000 bottles, of Tylenol 8 Hour extended-release caplets because of an odor. The Johnson & Johnson unit also expanded a January wholesale recall to include 10 lots, or about 718,000 packages or bottles, of Benadryl, Sudafed and Tylenol products. They were manufactured before the closure of McNeil's plant in Fort Washington, Pa.
Johnson & Johnson's McNeil Consumer Healthcare unit did not test Tylenol for chemical contaminants or conduct a formal investigation after receiving complaints in 2008 that the pain drug had a musty odor and might have caused gastrointestinal problems, FDA inspectors reported. A representative of McNeil said the company is "actively working" with the agency to resolve the issue.
Ortho-McNeil-Janssen Pharmaceuticals, a unit of Johnson & Johnson, filed a lawsuit against Sandoz to prevent the Novartis subsidiary from launching its version of oral contraceptive Ortho Tri-Cyclen LO until a patent expires in 2019. A spokesman for Novartis said Sandoz had no comment on the lawsuit.